CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 51 enrolled
Drug / intervention
Heated humified high-flow nasal cannula Oxygen +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03024112
NCT03024112N/ACompleted

Impact of Prophylactic High Flow Nasal Oxygen in Post-Operative Thoracic Surgical Patients

University of Colorado, Denver·interventional·Posted Jan 18, 2017·Updated Dec 5, 2017

In Brief

A clinical study evaluating Heated humified high-flow nasal cannula Oxygen and Standard oxygen therapy for Post-operative Pulmonary Complications. Completed, enrolled 51 participants across 1 site.

Detailed Summary

The Investigators goal was to study the effect of high flow nasal cannula oxygen (HFNC) on the rate of post-operative pulmonary complications in thoracic surgical patients. The Investigators hypothesis is that prophylactic HFNC oxygen, as compared to standard oxygen treatment, will reduce the incidence of postoperative pulmonary complications, improve post-operative pulmonary function, and reduce Intensive Care Unit (ICU) and hospital length of stay.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedJan 18, 2017
Enrollment StartAug 1, 2013
Primary CompletionJun 1, 2015
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 9.5 years ago

Interventions

Heated humified high-flow nasal cannula Oxygendevice

Standard oxygen therapyother